The small intestine in cardiac cachexia: A forgotten player of the game

International Journal of Cardiology

Volumn 147, Issue 1, 2011, Pages 186-187

  Celik, Turgay ^a   Yuksel, U Cagdas ^b  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Sarikamis Army District Hospital Turkey   (Turkey)

Author keywords

Cachexia; Chronic heart failure; Small intestine

Indexed keywords

CANRENONE; COLLAGEN; SPIRONOLACTONE;

APPETITE; BODY MASS; CACHEXIA; CALORIC INTAKE; CARDIAC CACHEXIA; ENERGY CONSUMPTION; FATIGUE; FOOD INTAKE; HEART FAILURE; HEART FUNCTION; HEART VENTRICLE REMODELING; HUMAN; INTESTINE PERFORATION; LETTER; MALABSORPTION; MUSCLE ATROPHY; MUSCLE WEAKNESS; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE; SURVIVAL; WEIGHT REDUCTION;

EID: 79951722296     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.12.039     Document Type: Article

References (16)

1. Sandek A, Valentova M, von Haehling S, Doehner W, Anker SD. The small intestine: A critical linkage of pathophsiology of cardiac cachexia. Int J Cardiol 2011;146:277-8.
2. Strassburg S, Anker SD. Metabolic and immunologic derangements in cardiac cachexia: where to from here? Heart Fail Rev 2006;11:57-64.
3. Anker SD, Steinborn W, Strassburg S. Cardiac cachexia. Ann Med 2004;36:518-29. (Pubitemid 39490961)
4. von Haehling S, Doehner W, Anker SD. Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res 2007;73:298-309. (Pubitemid 44937690)
5. Aquilani R, Opasich C, Verri M, et al. Is nutritional intake adequate in chronic heart failure patients? J Am Coll Cardiol 2003;42:1218-23.
6. Anker SD, Negassa A, Coats AJ, et al. A prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 2003;361:1077-83. (Pubitemid 36369559)
7. Kenchaiah S, Pocock SJ, Wang D, et al. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 2007;116:627-36. (Pubitemid 47356347)
8. Ralevic V. Splanchnic circulatory physiology. Hepatogastroenterology 1999;46(Suppl 2):1409-13. (Pubitemid 29313179)
9. Takala J. Determinants of splanchnic blood flow. Br J Anaesth 1996;77:50-8. (Pubitemid 26229912)
10. King D, Smith ML, Chapman TJ, Stockdale HR, Lye M. Fat malabsorption in elderly patients with cardiac cachexia. Age Ageing 1996;25:144-9. (Pubitemid 26091169)
11. King D, Smith ML, Lye M. Gastro-intestinal protein loss in elderly patients with cardiac cachexia. Age Ageing 1996;25:221-3. (Pubitemid 26152040)
12. Anker SD, Egerer KR, Volk HD, Kox WJ, Poole-Wilson PA, Coats AJ. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol 1997;79:1426-30.
13. Arutyunov GP, Kostyukevich OI, Serov RA, Rylova NV, Bylova NA. Collagen accumulation and dysfunctional mucosal barrier of the small intestine in patients with chronic heart failure. Int J Cardiol 2008;125:240-5.
14. Cittadini A, Monti MG, Isgaard J, et al. Aldosterone receptor blockade improves left ventricular remodeling and increases ventricular fibrillation threshold in experimental heart failure. Cardiovasc Res 2003;58:555-64. (Pubitemid 36694441)
15. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N Engl J Med 1999;341:709-17. (Pubitemid 29407370)
16. Shewan LG, Coats AJ. Ethics in the authorship and publishing of scientific articles. Int J Cardiol 2010;144:1-2.